VERTEX PHARMACEUTICALS INC / MA Deferred Revenue 2009-2017 | VRTX
What is deferred revenue?
Deferred revenue represents payments received in advance for goods or services that have not yet been delivered to customers.
What is VERTEX PHARMACEUTICALS INC / MA's current deferred revenue?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual deferred revenue for 2017 was $5.2M, a 13.92% decline from 2016. VERTEX PHARMACEUTICALS INC / MA deferred revenue for the quarter ending December 31, 2017 was $5.2M.
What was VERTEX PHARMACEUTICALS INC / MA's deferred revenue in 2016?
VERTEX PHARMACEUTICALS INC / MA annual deferred revenue for 2016 was $6.0M, a 63.15% decline from 2015.
What was VERTEX PHARMACEUTICALS INC / MA's deferred revenue in 2015?
VERTEX PHARMACEUTICALS INC / MA annual deferred revenue for 2015 was $16.3M, a 6.71% decline from 2014.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year deferred revenue CAGR?
VERTEX PHARMACEUTICALS INC / MA deferred revenue grew at a compound annual growth rate (CAGR) of 28.45% from FY2012 to FY2017, going from $27.6M to $5.2M over 5 years.
Year-over-year comparison from 10-K annual reports